167 research outputs found
In vivo microCT-based time-lapse morphometry reveals anatomical site-specific differences in bone (re)modeling serving as baseline parameters to detect early pathological events
The bone structure is very dynamic and continuously adapts its geometry to external stimuli by modeling and remodeling the mineralized tissue. In vivo microCT-based time-lapse morphometry is a powerful tool to study the temporal and spatial dynamics of bone (re)modeling. Here an advancement in the methodology to detect and quantify site-specific differences in bone (re)modeling of 12-week-old BALB/c nude mice is presented. We describe our method of quantifying new bone surface interface readouts and how these are influenced by bone curvature. This method is then used to compare bone surface (re)modeling in mice across different anatomical regions to demonstrate variations in the rate of change and spatial gradients thereof. Significant differences in bone (re)modeling baseline parameters between the metaphyseal and epiphyseal are shown, as well as cortical and trabecular bone of the distal femur and proximal tibia. These results are validated using conventional static in vivo microCT analysis. Finally, the insights from these new baseline values of physiological bone (re)modeling were used to evaluate pathological bone (re)modeling in a pilot breast cancer bone metastasis model. The method shows the potential to be suitable to detect early pathological events and track their spatio-temporal development in both cortical and trabecular bone. This advancement in (re)modeling surface analysis and defined baseline parameters according to distinct anatomical regions will be valuable to others investigating various disease models with site-distinct local alterations in bone (re)modeling.ER
Alginate hydrogels for in vivo bone regeneration : the immune competence of the animal model matters
Biomaterials with tunable biophysical properties hold great potential for tissue engineering. The adaptive immune system plays an important role in bone regeneration. Our goal is to investigate the regeneration potential of cell-laden alginate hydrogels depending on the immune status of the animal model. Specifically, the regeneration potential of rat mesenchymal stromal cell (MSC)-laden, void-forming alginate hydrogels, with a stiffness optimized for osteogenic differentiation, is studied in 5 mm critical-sized femoral defects, in both T-cell deficient athymic RNU nude rats and immunocompetent Sprague Dawley rats. Bone volume fraction, bone mineral density and tissue mineral density are higher for athymic RNU nude rats 6 weeks post-surgery. Additionally, these animals show a significantly higher number of total cells and cells with non-lymphocyte morphology at the defect site, while the number of cells with lymphocyte-like morphology is lower. Hydrogel degradation is slower and the remaining alginate fragments are surrounded by a thicker fibrous capsule. Ossification islands originating from alginate residues suggest that encapsulated MSCs differentiate into the osteogenic lineage and initiate the mineralization process. However, this effect is insufficient to fully bridge the bone defect in both animal models. Alginate hydrogels can be used to deliver MSCs and thereby recruit endogenous cells through paracrine signaling, but additional osteogenic stimuli are needed to regenerate critical-sized segmental femoral defects
Infrared Observations of the Candidate LBV 1806-20 & Nearby Cluster Stars
We report near-infrared photometry, spectroscopy, and speckle imaging of the
hot, luminous star we identify as candidate LBV 1806-20. We also present
photometry and spectroscopy of 3 nearby stars, which are members of the same
star cluster containing LBV 1806-20 and SGR 1806-20. The spectroscopy and
photometry show that LBV 1806-20 is similar in many respects to the luminous
``Pistol Star'', albeit with some important differences. They also provide
estimates of the effective temperature and reddening of LBV 1806-20, and
confirm distance estimates, leading to a best estimate for the luminosity of
this star of . The nearby cluster stars have
spectral types and inferred absolute magnitudes which confirm the distance (and
thus luminosity) estimate for LBV 1806-20. If we drop kinematic measurements of
the distance ( kpc), we have a lower limit on the distance
of kpc, and on the luminosity of , based on
the cluster stars. If we drop both the kinematic and cluster star indicators
for distance, an ammonia absorption feature sets yet another lower limit to the
distance of kpc, with a corresponding luminosity estimate of for the candidate LBV 1806-20. Furthermore, based on very high
angular-resolution speckle images, we determine that LBV 1806-20 is not a
cluster of stars, but is rather a single star or binary system. Simple
arguments based on the Eddington luminosity lead to an estimate of the total
mass of LBV 1806-20 (single or binary) exceeding . We discuss
the possible uncertainties in these results, and their implications for the
star formation history of this cluster.Comment: 36 pages, including 8 figures (Figures 1 and 7 in JPG format due to
space); Accepted for publication in Ap
Measurement of p + d -> 3He + eta in S(11) Resonance
We have measured the reaction p + d -> 3He + eta at a proton beam energy of
980 MeV, which is 88.5 MeV above threshold using the new ``germanium wall''
detector system. A missing--mass resolution of the detector system of 2.6% was
achieved. The angular distribution of the meson is forward peaked. We found a
total cross section of (573 +- 83(stat.) +- 69(syst.))nb. The excitation
function for the present reaction is described by a Breit Wigner form with
parameters from photoproduction.Comment: 8 pages, 2 figures, corrected typos in heade
Meson Production in p+d Reactions
The production of neutral and charged pions as well as eta mesons is studied
in the Delta and N* resonance region, respectively. Heavy A=3 recoils were
measured with the GEM detector. The differential cross sections covering the
full angular range are compared with model calculations.Comment: 4 pages, latex, 4 figures, talk presented at the XVIIth European
Conference on Few-Body Problems in Physics, Evora, Portugal, September 2000;
to be published in Nucl. Phys.
Prion infectivity in the spleen of a <em>PRNP</em> heterozygous individual with subclinical variant Creutzfeldt-Jakob disease
Blood transfusion has been identified as a source of human-to-human transmission of variant CreutzfeldtâJakob disease. Three cases of variant CreutzfeldtâJakob disease have been identified following red cell transfusions from donors who subsequently developed variant CreutzfeldtâJakob disease and an asymptomatic red cell transfusion recipient, who did not die of variant CreutzfeldtâJakob disease, has been identified with prion protein deposition in the spleen and a lymph node, but not the brain. This individual was heterozygous (MV) at codon 129 of the prion protein gene (PRNP), whereas all previous definite and probable cases of variant CreutzfeldtâJakob disease have been methionine homozygotes (MM). A critical question for public health is whether the prion protein deposition reported in peripheral tissues from this MV individual correlates with infectivity. Additionally it is important to establish whether the PRNP codon 129 genotype has influenced the transmission characteristics of the infectious agent. Brain and spleen from the MV blood recipient were inoculated into murine strains that have consistently demonstrated transmission of the variant CreutzfeldtâJakob disease agent. Mice were assessed for clinical and pathological signs of disease and transmission data were compared with other transmission studies in variant CreutzfeldtâJakob disease, including those on the spleen and brain of the donor to the index case. Transmission of variant CreutzfeldtâJakob disease was observed from the MV blood recipient spleen, but not from the brain, whereas there was transmission from both spleen and brain tissues from the red blood cell donor. Longer incubation times were observed for the blood donor spleen inoculum compared with the blood donor brain inoculum, suggesting lower titres of infectivity in the spleen. The distribution of vacuolar pathology and abnormal prion protein in infected mice were similar following inoculation with both donor and recipient spleen homogenates, providing initial evidence of similar transmission properties after propagation in PRNP codon 129 MV and MM individuals. These studies demonstrate that spleen tissue from a PRNP MV genotype individual can propagate the variant CreutzfeldtâJakob disease agent and that the infectious agent can be present in the spleen without CNS involvement
Uncertainty in the Tail of the Variant Creutzfeldt-Jakob Disease Epidemic in the UK
Despite low case numbers the variant Creutzfeldt-Jakob disease epidemic poses many challenges for public health planning due to remaining uncertainties in disease biology and transmission routes. We develop a stochastic model for variant CJD transmission, taking into account the known transmission routes (food and red-cell transfusion) to assess the remaining uncertainty in the epidemic. We use Bayesian methods to obtain scenarios consistent with current data. Our results show a potentially long but uncertain tail in the epidemic, with a peak annual incidence of around 11 cases, but the 95% credibility interval between 1 and 65 cases. These cases are predicted to be due to past food-borne transmissions occurring in previously mostly unaffected genotypes and to transmissions via blood transfusion in all genotypes. However, we also show that the latter are unlikely to be identifiable as transfusion-associated cases by case-linking. Regardless of the numbers of future cases, even in the absence of any further control measures, we do not find any self-sustaining epidemics
Nowcasting pandemic influenza A/H1N1 2009 hospitalizations in the Netherlands
During emerging epidemics of infectious diseases, it is vital to have up-to-date information on epidemic trends, such as incidence or health care demand, because hospitals and intensive care units have limited excess capacity. However, real-time tracking of epidemics is difficult, because of the inherent delay between onset of symptoms or hospitalizations, and reporting. We propose a robust algorithm to correct for reporting delays, using the observed distribution of reporting delays. We apply the algorithm to pandemic influenza A/H1N1 2009 hospitalizations as reported in the Netherlands. We show that the proposed algorithm is able to provide unbiased predictions of the actual number of hospitalizations in real-time during the ascent and descent of the epidemic. The real-time predictions of admissions are useful to adjust planning in hospitals to avoid exceeding their capacity
- âŠ